Skip to content

Drug interactions

Pitavastatin + Tafamidis

Severity: Moderate

Pitavastatin and Tafamidis: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tafamidis inhibits BCRP in vitro and may raise exposure to BCRP substrates such as pitavastatin. The clinical effect is probably modest but could raise the risk of statin muscle effects.

What this interaction means in plain words

Pitavastatin and Tafamidis can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pitavastatin belongs to Cardiovascular; Tafamidis belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Tafamidis inhibits BCRP efflux, which may increase pitavastatin exposure.

What to do

Monitor for myalgia or weakness and use the lowest effective pitavastatin dose. Check CK if symptoms develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pitavastatin and Tafamidis, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pitavastatin with Tafamidis?

MediHelp rates the interaction as moderate. Pitavastatin and Tafamidis can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tafamidis inhibits BCRP in vitro and may raise exposure to BCRP substrates such as pitavastatin. The clinical effect is probably modest but could raise the risk of statin muscle effects.

How serious is the interaction between Pitavastatin and Tafamidis?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for myalgia or weakness and use the lowest effective pitavastatin dose. Check CK if symptoms develop.

What other medicines interact with Pitavastatin?

MediHelp also lists interactions of Pitavastatin with, for example, Cyclosporine, Cyclosporin, Erythromycin base. The full list is on the Pitavastatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in